Elevated levels of circulating triglycerides and increased arterial stiffness are associated with cardiovascular disease. Numerous studies have reported an association between levels of circulating triglycerides and arterial stiffness. We used Mendelian randomization to test whether this association is causal. We investigated the association between circulating triglyceride levels, the apolipoprotein A-V (ApoA5) -1131T4C single nucleotide polymorphism and brachial-ankle pulse wave velocity (baPWV) by examining data from 4421 subjects aged 18-74 years who were recruited from the Chinese population. baPWV was significantly associated with the levels of circulating triglycerides after adjusting for age, sex, body mass index (BMI), systolic blood pressure, heart rate, waist-to-hip ratio, antihypertensive treatment and diabetes mellitus status. The À 1131C allele was associated with a 5% (95% confidence interval 3-8%) increase in circulating triglycerides (adjusted for age, sex, BMI, waist-to-hip ratio, diabetes mellitus and antihypertensive treatment). Instrumental variable analysis showed that genetically elevated levels of circulating triglycerides were not associated with increased baPWV. These results do not support the hypothesis that levels of circulating triglycerides have a causal role in the development of arterial stiffness.
INTRODUCTION
Elevated levels of circulating triglycerides [1] [2] [3] and increased arterial stiffness [4] [5] [6] are associated with cardiovascular disease. A recent collaborative analysis of 101 studies has demonstrated a causal association between triglyceride concentration and coronary heart disease. 7 One potential mechanism linking triglyceride-mediated pathways to cardiovascular disease is arterial stiffening. Numerous studies have reported an association between levels of circulating triglycerides and arterial stiffness. [8] [9] [10] [11] However, some studies found either a weak relationship or no relationship between the two. [12] [13] [14] Observational studies have residual problems with confounding factors and reverse causality; therefore, whether this relationship is causal remains unknown.
One approach in solving these problems is to use Mendelian randomization. Mendelian randomization is the term applied to the random allocation of alleles from parents to offspring, which results in a distribution of genetic variants that is generally independent of confounders such as environmental, behavioral or socioeconomic factors. 15 Therefore, if the levels of circulating triglycerides are causally related to arterial stiffness, increased arterial stiffness would be expected in those persons with the genotype that generates higher levels of circulating triglycerides.
The aim of our study was to determine whether there is a causal relationship between levels of circulating triglycerides and increased arterial stiffness using Mendelian randomization. First, to test whether levels of circulating triglycerides are associated with brachial-ankle pulse wave velocity (baPWV), a widely recognized measure of arterial stiffness; 16, 17 second, to determine whether the association between the apolipoprotein A-V (ApoA5) -1131T4C polymorphism and triglyceride levels could be replicated in our study population. We investigated this single nucleotide polymorphism because it was widely studied in population studies and strongly related to triglyceride concentration in a dose-dependent manner; [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] and third, to investigate whether the ApoA5 -1131T4C polymorphism is associated with an increase in baPWV, consistent with its effect on triglyceride levels.
METHODS

Study population
Proportionately stratified random sampling was used to select a representative sample from the towns of Baqiao and Songqiao in Gaoyou, a rural area 170 km north of Nanjing, China. The sample was stratified by sex and age based on population data obtained from the local authorities. The aim of this study was to investigate the prevalence of common diseases in this rural area, and there were no a priori exclusion criteria. We first selected 5000 subjects from Baqiao, however, the participant rate was lower than the expected 80%, so we additionally selected 1000 subjects from two villages of Songqiao. Finally, 6000 subjects aged 18-74 years old, were selected and invited to participate in the study. In the period from January to May 2010, 4536 subjects participated in the study, including 3918 subjects from Baqiao and 618 subjects from Songqiao; the response rates were 78.4% and 61.8%, respectively. We excluded 115 subjects because of incomplete anthropometric measurements (n ¼ 53), a lack of information on their baPWV (n ¼ 45), the use of a lipid-lowering medication (n ¼ 4), and genotyping failure (n ¼ 13), resulting in 4421 subjects who were suitable for statistical analysis. Information on the population structure in each area is in Supplementary Table 1 . According to our previous study, the prevalence and standardized prevalence of atrial fibrillation in Baqiao was 0.87% and 0.44%, respectively, and similar to other populations in China. 28 This study complied with the Declaration of Helsinki. The protocol was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University. Informed consent was obtained and signed by each participant.
Field work
The subjects fasted overnight and abstained from caffeine, tea, tobacco and alcohol for at least 1 h prior to undergoing measurement. We used a standardized questionnaire to collect information on the subject's medical history, smoking habits, alcohol intake, average household monthly income and use of medications. Blood pressure was measured by trained examiners using a mercury sphygmomanometer according to a standard protocol. After each subject rested for at least 5 min in the sitting position, his or her blood pressure was measured three times on the right arm with the arm cuff maintained at the heart level. These three readings were averaged for the analysis. Hypertension was diagnosed if the average of the three blood pressure readings was at least 140 mm Hg systolic pressure or 90 mm Hg diastolic pressure, or if the subjects were on antihypertensive medication. Diabetes was diagnosed if the fasting serum glucose concentration was at least 7.0 mmol l À 1 or if the subject was on an antidiabetic medication or insulin treatment. Weight and height were measured with the subjects wearing light indoor clothing without shoes. Body mass index (BMI) was calculated using the subject's weight in kilograms divided by height in meters squared (kg m À 2 ). The waist-to-hip ratio was calculated using the smallest circumference at the waist divided by the largest circumference at the hip.
Pulse wave velocity measurement
The baPWV was assessed noninvasively using a VP-1000 automated PWV/ ABI analyzer (Colin Co. Ltd., Komaki, Japan), which simultaneously measured the pulse volumes in the brachial and ankle arteries using an oscillometric method as well as the bilateral arm and ankle blood pressures. The subjects were examined in a supine position after a period of rest of at least 5 min. The cuffs were wrapped on both sides of the brachium and ankle, and contained a plethysmographic sensor that determined the waveform data. The mean of the right and left baPWV values was used for the analysis. Additionally, the heart rate was automatically recorded and used for the analysis.
Laboratory measurements
Routine biochemical measurements of lipid profiles, including triglycerides, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were performed in the central laboratory of the First Affiliated Hospital with Nanjing Medical University (Nanjing, China) by an automated analyzer (Chemistry Analyzer AU2700, Olympus Medical Engineering Company, Tokyo, Japan).
DNA genotyping
Genomic DNA was extracted from white blood cells using a commercially available kit and the BioRobot M48 Workstation (Qiagen Inc., Hilden, Germany) according to the manufacturer's instructions. We genotyped the ApoA5 -1131T4C polymorphism (rs662799) using fluorogenic allelespecific TaqMan MGB probes with the ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and LightCycler 480 Real-Time PCR System (Roche Diagnostics, Mannheim, Germany) following a standard protocol (TaqMan SNP Genotyping Assays Protocol, PN 4332856C, Applied Biosystems). Random duplicates were used as a quality control.
Instrumental variable analysis
To estimate the causal effect of triglycerides on baPWV, we performed instrumental variable (IV) analysis, in which ApoA5 genotype was used as IV for the unconfounded and unbiased effect of triglycerides. First, we generated z scores of common logarithm of triglycerides and baPWV, and tested the correlation between the two variables with linear regression. Then, we compared results from the IV-based estimation of the association of triglyceride genotype with predicted values of baPWV from linear regression. Finally, the test of endogeneity was assessed.
Statistics
For database management and statistical analysis, we used SAS software, version 9.2 (SAS Institute, Cary, NC, USA). Continuous variables were expressed as the mean ± s.d. Common logarithmic transformations were performed for distributions that were significantly skewed before analysis. Differences among the groups were tested using analysis of variance with post-hoc least significant difference t-tests. Pearson's correlation coefficients were used to examine the bivariate associations between variables.
Stepwise forward regression analyses were used to evaluate the factors that were independently associated with baPWV in the whole population; P-values for covariates to be included in the model were set at 0.15. HardyWeinberg equilibrium was assessed using the w 2 test. P-values o0.05 were considered statistically significant, and all tests were two-tailed.
RESULTS
Characteristics of the study population according to ApoA5 genotype The characteristics of the study population according to ApoA5 genotype are shown in Table 1 . The ApoA5 -1131T4C genotype distribution among the 4421 subjects was as follows: 2204 (49.9%) for the TT genotype, 396 (9.0%) for the CC genotype and the rest 1821 (41.2%) for the TC genotype. The minor C allele frequency of ApoA5 -1131T4C was 0.3. These frequencies did not deviate significantly from Hardy-Weinberg equilibrium (P ¼ 0.47) and similar to those in the HapMap CHB population (P ¼ 0.64) (http://hapmap.ncbi.nlm.nih.gov/). No significant differences were seen between the ApoA5 genotypes with respect to age, waist-tohip ratio, systolic blood pressure, diastolic blood pressure, heart rate, total cholesterol, low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol and monthly income. Details of gender-specific characteristics of the study population according to the ApoA5 -1131T4C genotype are given in Supplementary  Table 2 .
Triglyceride levels in relation to baPWV The Pearson's correlation analysis showed a significant association between baPWV and the common logarithm of triglycerides, and the correlation coefficient was 0.18 (Po0.001; Figure 1 ). In a stepwise forward linear regression model, the common logarithm of triglycerides was independently associated with the baPWV after adjusting for age, sex, BMI, waist-to-hip ratio, systolic blood pressure, heart rate, antihypertensive treatment and diabetes mellitus. By contrast, smoking status, diastolic blood pressure, hypertension, alcoholic intake, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and the ApoA5 -1131T4C polymorphism were not significantly or independently associated with baPWV and were excluded from the regression model based on the pre-specified P-value of 0.15 (Table 2 ).
ApoA5 genotype and its relation to the levels of circulating triglycerides We examined the association between the ApoA5 -1131T4C polymorphism and circulating triglyceride concentrations (Table 3) . Each ApoA5 -1131C allele was associated with a 5% (95% confidence interval (CI) 2-7%) increase in the level of circulating triglycerides. After adjusting for age, sex, systolic blood pressure, heart rate, BMI, waist-to-hip ratio, diabetes mellitus and antihypertensive treatment, there was still a 5% (95% CI 3-8%) increase in the level of circulating triglycerides for each C allele.
Comparison between the observed and IV-based estimated baPWV by ApoA5 genotype A directed acyclic graph (Figure 2 ) was adopted to clarify the associations between these variables. First, the observed allelespecific changes in circulating triglyceride z scores and baPWV z scores were calculated (Po0.001 and P ¼ 0.75, respectively), and then we assessed the observational association between triglyceride z scores and baPWV z scores with regression model (Po0.001) and the predicted values of baPWV were saved for the IV (ApoA5 -1131T4C genotype)-based estimated baPWV calculation. After that, the endogeneity test was calculated, whereby the slope of the regression line from first stage of IV analysis (observed allelespecific change in baPWV z score) was significantly different from the slope of the regression line when using predicted values of baPWV by genotype from second stage IV analysis (Po0.001).
DISCUSSION
To our knowledge, this is the first study to investigate whether triglyceride levels are causally associated with arterial stiffness by using Mendelian randomization. The principal finding of our study is that the C allele of the ApoA5 -1131T4C polymorphism is associated with a 5% (95% CI 3-8%) increase in levels of circulating triglycerides (adjusted for age, sex, systolic blood pressure, heart rate, BMI, waist-to-hip ratio, diabetes mellitus and antihypertensive treatment) and IV-based estimated changes in baPWV, but is not associated with observed changes in baPWV. The results suggest that although levels of circulating triglycerides are associated with baPWV, triglycerides do not have a causal role in the development of arterial stiffness.
Our findings were consistent with some previous studies. In a study of 12 517 subjects who were taking no medications and had no history of cardiovascular disease, triglyceride levels were independently associated with baPWV in both genders. 8 Nakanishi et al. 9 found that age-adjusted mean baPWV values were greater in subjects with high triglyceride levels (X1.69 mmol l À 1 ), which explained the 2.3% variance in baPWV. McEniery et al. 10 investigated prospective risk factors for aortic stiffness in men with a 20-year follow-up. In that study, aortic pulse wave velocity was independently associated with baseline triglyceride level after adjusting for age, mean arterial pressure and heart rate. Ho et al.
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enrolled a total of 2188 subjects in a population-based study in Taiwan, and they found baPWV to be strongly associated with triglycerides after adjusting for age, gender, BMI, waist circumference, systolic blood pressure, diastolic blood pressure and fasting glucose. However, in many other observational studies, there was either no such linkage or the correlation was not significant after adjusting for confounders. [12] [13] [14] We also replicated the association between the ApoA5 -1131T4C polymorphism and triglyceride levels. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Genomewide association studies had reported that polymorphisms in or near the ApoA5 gene were among the strongest known genetic determinants of triglyceride concentration. 29 Animal and human studies support the role of ApoA5 in triglyceride metabolism. 18 Martin et al. 19 found that -1131C allele was associated with fasting triglyceride-raising effects (11%, P ¼ 0.008) in healthy young men. In the Framingham Heart Study, the ApoA5 -1131T4C Figure 1 . Scatter plots illustrating the relationship between baPWV and the common logarithm of triglycerides (r ¼ 0.18, Po0.001) for the total study population. Triglycerides and pulse wave velocity W-M Yao et al polymorphism explained 0.51% of natural log-transformed plasma triglyceride variance in females and 0.78% in males. 20 Klos et al.
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showed that plasma triglycerides were significantly (Po0.01) associated with the ApoA5 -1131C allele in white males, and the ApoA5 -1131T4C polymorphism accounted for 1.57% of the total variation in natural log-transformed plasma triglyceride levels. This association was also found in Chinese populations. In a study of 167 Chinese men, Baum et al. 26 reported that more subjects with high triglycerides (X1.7 mmol l À 1 ) had one or two copies of the ApoA5 -1131C allele (67%) than did low-triglyceride subjects (48%). Jiang et al. 27 enrolled 1375 subjects from Hong Kong and 1996 subjects from Guangzhou and found that the ApoA5 -1131T4C polymorphism was strongly correlated with logtransformed triglyceride levels among subjects from Hong Kong (b ¼ 0.192, Po0.001) and Guangzhou (b ¼ 0.159, Po0.001), and this correlation was significant irrespective of other effects.
The mechanism linking the ApoA5 -1131T4C polymorphism and levels of circulating triglycerides is complex and not fully established. There are two possible mechanisms for the role of ApoA5 in the regulation of circulating triglyceride levels that have been proposed: (1) ApoA5 influences the removal of triglycerides from plasma and (2) ApoA5 influences the secretion of very lowdensity lipoproteins. 30 As circulating triglyceride levels have been shown to have a robust association with ApoA5 -1131T4C, we hypothesized that if levels of circulating triglycerides were causally related to baPWV, we would expect a difference in baPWV according to ApoA5 genotype proportionate to the effect of the genotype on levels of circulating triglycerides. However, there was no evidence of an association between ApoA5 -1131T4C polymorphism and baPWV in our study. These results do not support the hypothesis that the level of circulating triglycerides has a causal role in the development of arterial stiffness and suggest a possible confounding effect in the relationship between levels of circulating triglycerides and baPWV for which previous studies have not adjusted.
In conclusion, we show that genetic variants that are associated with increases in circulating triglyceride levels are not associated with increased baPWV. This finding suggests that the higher circulating triglyceride level with higher baPWV observed in epidemiologic studies may reflect confounding and reverse causation, rather than a causal effect.
The present study has to be interpreted within the context of its limitations. First, our study population has a high prevalence of hypertension. Therefore, our results might not be generalizable to the entire Chinese population. Second, the ApoA5 -1131T4C polymorphism had only a small effect on the levels of circulating triglycerides in our study population. Therefore, we cannot exclude the possibility that the null findings of the association between the ApoA5 -1131T4C polymorphism and baPWV might be due to a type II error. Third, it is possible that the locus under study is in linkage disequilibrium with another polymorphic locus, with the effect that the polymorphism under investigation is confounded by the influence of the other unknown polymorphisms. Therefore, we cannot exclude the possibility of other locus which in linkage disequilibrium influenced the levels of circulating triglycerides. Fourth, the ApoA5 -1131T4C might have pleiotropic effects on other serum lipid profiles including total cholesterol, low-density lipoprotein and high-density lipoprotein. 31 However, in our study, no effects on other serum lipids were found. Finally, carotid-femoral pulse wave velocity via the aortic route is accepted as the gold standard measure of arterial stiffness and has established reference values. 32 On the other hand, there were limited data on baPWV as an independent marker of cardiovascular mortality via prospective studies. However, previous studies showed that baPWV closely correlates with aortic pulse wave velocity and has a role as a noninvasive protocol to assess risk. 16, 17 Further studies are needed to confirm our findings.
What is known about this topic? Elevated levels of circulating triglycerides and increased arterial stiffness are associated with cardiovascular disease. Linkage between levels of circulating triglycerides and arterial stiffness is a controversial issue. ApoA5 -1131T4C polymorphism is strongly related to triglyceride concentration in a dose-dependent manner.
What this study adds Levels of circulating triglycerides are associated with baPWV, but triglycerides do not have a causal role in the development of arterial stiffness.
